Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages
- PMID: 2477488
- PMCID: PMC2189482
- DOI: 10.1084/jem.170.4.1231
Lipopolysaccharide (LPS) binding protein opsonizes LPS-bearing particles for recognition by a novel receptor on macrophages
Abstract
Lipopolysaccharide binding protein (LBP) is an acute-phase reactant that binds bacterial LPS. We show that LBP binds to the surface of live Salmonella and to LPS coated erythrocytes (ELPS), and strongly enhances the attachment of these particles to macrophages. LBP bridges LPS-coated particles to macrophages (MO) by first binding to the LPS, then binding to MO. Pretreatment of ELPS with LBP enabled binding to MO, but pretreatment of MO had no effect. Moreover, MO did not recognize erythrocytes coated with LBP unless LPS was also added, thus suggesting that interaction of LBP with LPS results in a conformational change in LBP that allows recognition by MO. Binding of LBP-coated particles appears to be mediated by a receptor found on blood monocytes and MO but not on other leukocytes or umbilical vein endothelium. The receptor is mobile in the plane of the membrane since binding activity on MO was downmodulated upon spreading of cells on surfaces coated with LBP-LPS complexes. The receptor appears to be distinct from other opsonic receptors since downmodulation of CR1, CR3, Fc gamma RI, Fc gamma RII, and Fc gamma RIII with mAbs did not affect binding of LBP-coated particles, and leukocytes from CD18-deficient patients bound LBP-coated particles normally. Coating of erythrocytes with LBP-LPS complexes strongly enhanced phagocytosis observed in the presence of suboptimal amounts of anti-erythrocyte IgG. However, binding mediated by LBP-LPS complexes alone caused neither phagocytosis of the LBP-coated erythrocytes nor initiation of an oxidative burst. The results of our studies define LBP as an opsonin. During the acute phase, LBP can be expected to bind gram-negative bacteria and bacterial fragments and promote the interaction of coated bacteria with phagocytes.
Similar articles
-
Septin: a factor in plasma that opsonizes lipopolysaccharide-bearing particles for recognition by CD14 on phagocytes.J Exp Med. 1992 Sep 1;176(3):719-27. doi: 10.1084/jem.176.3.719. J Exp Med. 1992. PMID: 1380975 Free PMC article.
-
Lipopolysaccharide-induced suppression of erythrocyte binding and phagocytosis via Fc gamma RI, Fc gamma RII, Fc gamma RIII, and CR3 receptors in murine macrophages.J Leukoc Biol. 1993 Jul;54(1):81-8. doi: 10.1002/jlb.54.1.81. J Leukoc Biol. 1993. PMID: 8336082
-
Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18.J Immunol. 1999 Apr 1;162(7):4220-5. J Immunol. 1999. PMID: 10201950
-
Fighting infection: the role of lipopolysaccharide binding proteins CD14 and LBP.Pathobiology. 1999;67(5-6):227-9. doi: 10.1159/000028097. Pathobiology. 1999. PMID: 10725789 Review.
-
Regulatory mechanisms of host responsiveness to endotoxin (lipopolysaccharide).Pathobiology. 1991;59(3):185-8. doi: 10.1159/000163641. Pathobiology. 1991. PMID: 1883513 Review.
Cited by
-
Early life stress inhibits expression of a novel innate immune pathway in the developing hippocampus.Neuropsychopharmacology. 2012 Jan;37(2):567-80. doi: 10.1038/npp.2011.239. Epub 2011 Oct 12. Neuropsychopharmacology. 2012. PMID: 21993208 Free PMC article.
-
Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.J Exp Med. 1994 Jan 1;179(1):269-77. doi: 10.1084/jem.179.1.269. J Exp Med. 1994. PMID: 7505800 Free PMC article.
-
Of Flies and Men-The Discovery of TLRs.Cells. 2022 Oct 5;11(19):3127. doi: 10.3390/cells11193127. Cells. 2022. PMID: 36231089 Free PMC article. Review.
-
Identification and characterization of lipopolysaccharide-binding proteins on human peripheral blood cell populations.Infect Immun. 1992 Mar;60(3):845-52. doi: 10.1128/iai.60.3.845-852.1992. Infect Immun. 1992. PMID: 1371770 Free PMC article.
-
Significance of lipopolysaccharide-binding protein (an acute phase protein) in monitoring critically ill patients.Crit Care. 2003 Dec;7(6):R154-9. doi: 10.1186/cc2386. Epub 2003 Oct 1. Crit Care. 2003. PMID: 14624690 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous